Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest diarrhea Stories

2013-01-07 08:29:21

JERSEY CITY, N.J., Jan. 7, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today provided an update on 2012 sales for DIFICID (fidaxomicin) tablets, an antibacterial drug launched in July 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age or older in the United States. Preliminary 2012 gross product sales in the United States and Canada totaled $74.4 million. Preliminary gross product sales for the fourth quarter of 2012...

2013-01-02 16:22:49

Amazon tree-derived medicine cleared for usage in HIV patients with diarrhea AUSTIN, Texas, Jan. 2, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Botanical Council: (Logo: http://photos.prnewswire.com/prnh/20100430/DC95601LOGO) On New Year's Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq(TM), Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) -- marking the second time a botanical, and the first...

2012-12-31 05:02:21

Irritable Bowel Syndrome patient-expert Heather Van Vorous pioneered comprehensive dietary guidelines for managing IBS over a decade ago. Today, her ground-breaking book Eating for IBS celebrates more than 10 years as a best-seller on special diet lists and over 250,000 copies sold worldwide. Seattle, WA (PRWEB) December 30, 2012 If you´re new to the dietary management of Irritable Bowel Syndrome, learning what you can and can´t eat without triggering painful symptoms used to be...

2012-12-19 12:25:01

SAN BRUNO, Calif., Dec. 19, 2012 /PRNewswire/ -- Recent data suggests that the average American is bombarded with up to 5,000 varying media messages on a daily basis, which can make it tricky to discern fact from fiction. When it comes to your health, there should be absolutely no doubt that the products you select are effectively working to produce the desired results. This is especially true when it comes to the use of probiotics with antibiotics, because some forms are less effective when...

2012-12-17 08:25:53

GAITHERSBURG, Md., Dec. 17, 2012 /PRNewswire/ -- MedImmune, the global biologics arm of AstraZeneca, announced that it has signed an in-licensing agreement with Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) for Progenics' Clostridium difficile late-stage preclinical program. The agreement was led by MedImmune's Infectious Diseases & Vaccines Innovative Medicines (iMed) Unit. Clostridium difficile infections are the leading cause of hospital-acquired bacterial infections in the U.S. and...

Detection Dog Detects Hospital Infection With High Rate Of Accuracy
2012-12-14 10:21:59

[Watch Video: Using Dogs To Sniff Out A Diagnosis] Lawrence LeBlond for redOrbit.com - Your Universe Online Humans have relied on dogs for millennia. Since first being domesticated some 15,000 years ago, dogs have been “man´s best friend” through thick and thin. We have used dogs for work, for sport and for play. They have provided invaluable services to mankind, providing their unique skills as police dogs, seeing-eye dogs, and perhaps their greatest attribute as...

2012-12-10 17:03:48

Researchers track the emergence and global spread of healthcare associated Clostridium difficile Researchers show that the global epidemic of Clostridium difficile 027/NAP1/BI in the early to mid-2000s was caused by the spread of two different but highly related strains of the bacterium rather than one as was previously thought. The spread and persistence of both epidemics were driven by the acquisition of resistance to a frontline antibiotic. Unlike many other healthcare-associated...

2012-12-03 16:23:36

ROCKVILLE, Md., Dec. 3, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today that the Company closed the previously announced deal with Prev AbR LLC (Prev) and acquired a series of beta-lactamase compounds (P1A, P2A and P3A) and related assets targeting the prevention of Clostridium difficile (C. diff) infection. Utilizing the newly acquired biologic compounds, Synthetic...

2012-12-03 08:27:30

JERSEY CITY, N.J., Dec. 3, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today the execution of an exclusive agreement with AstraZeneca to commercialize fidaxomicin tablets for the treatment of Clostridium difficile Infection (CDI) in South America, including Brazil, Central America, Mexico and the Caribbean. (Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO) Under the terms of the agreement AstraZeneca is responsible for the commercialization of...

2012-11-28 12:26:33

BARCELONA, Spain and CAMBRIDGE, Massachusetts, November 28, 2012 /PRNewswire/ -- - Constella(R) (linaclotide) is the first and only medicine approved by the European Commission for the symptomatic treatment of moderate to severe IBS-C in adults, that improves abdominal pain/discomfort, bloating and constipation - First launches in Europe are expected in the first half of 2013 - IBS-C is a functional gastrointestinal disorder...


Latest diarrhea Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

11_f79bc6a70a3ca6d0849bbfc3e310d871
2011-02-23 20:42:46

Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...

45_7b9aa20b6263a73b7fcd4e869f868330
2011-02-17 17:29:15

Norovirus is an RNA virus that causes approximately 90% of epidemic non-bacterial outbreaks of gastroenteritis around the world. It may also be responsible for 50% of all foodborne outbreaks of gastroenteritis in the U.S. It can affect people of all ages and is transmitted by food or water that is contaminated, by person-to-person contact, and through aerosolization of the virus and subsequent contamination of surfaces. Immunity is usually incomplete and temporary after infection. People...

More Articles (3 articles) »